Latest news
Vivani Medical announces full enrollment, initial dosing in SLIM-1 trial - TipRanksTipRanks · Thu, 06 Aug 2026 19:08:53 GMTVivani Medical Completes Enrollment, Dosing in Phase 1 SLIM-1 Trial - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 15:00:07 GMTVivani Medical Announces Successful Dosing of All Participants in SLIM-1, a Phase 1 Trial Evaluating NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 12:00:00 GMTSemaglutide implant trial doses all 20 participants; data expected in November - Stock TitanStock Titan · Thu, 06 Aug 2026 12:00:00 GMTVivani Medical (VANI) to Announce Earnings on Wednesday - MarketBeatMarketBeat · Wed, 05 Aug 2026 14:12:08 GMTVivani Medical (VANI) awards CEO 200K stock options and 100K RSUs - Stock TitanStock Titan · Fri, 31 Jul 2026 00:41:54 GMTVivani Medical (NASDAQ: VANI) awards CFO 75,000 options and RSUs - Stock TitanStock Titan · Fri, 31 Jul 2026 00:41:54 GMTVivani Medical (VANI) awards 70,000 options and 35,000 RSUs to CBO - Stock TitanStock Titan · Fri, 31 Jul 2026 00:41:54 GMT